Constronics Infra Ltd - Stock Valuation and Financial Performance

BSE: 523844 | NSE: | Hospital & Healthcare Services | Small Cap

Constronics Infra Share Price

39.50 0.76 1.96%
as on 18-Mar'24 16:59

DeciZen - make an informed investing decision on Constronics Infra

M-Cap below 100cr DeciZen not available

Constronics Infra stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
28.5 Cr.
52-wk low:
5.1
52-wk high:
39.5

Is Constronics Infra Ltd an attractive stock to invest in?

1. Is Constronics Infra Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Constronics Infra Ltd is a below average quality company.

2. Is Constronics Infra Ltd undervalued or overvalued?

The key valuation ratios of Constronics Infra Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Constronics Infra Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Constronics Infra Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Constronics Infra:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Constronics Infra Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % -6.8%-10.8%-12.1%-14.2%-20.2%-3%11.1%-9.1%18.6%6%-
Value Creation
Index
-1.5-1.8-1.9-2.0-2.4-1.2-0.2-1.70.3-0.6-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 000000.61.91.52.20.80
Sales YoY Gr.-NANANANANA241.8%-18.6%41.8%-62.2%-
Adj EPS -0.1-0.1-0.1-0.1-0.2-00.1-0.10.20.10
YoY Gr.-NANANANANANA-184.6%NA-66.7%-
BVPS (₹) 1.21.10.90.8000.100.30.30.5
Adj Net
Profit
-0.1-0.1-0.1-0.1-0.100.1-0.10.20.10
Cash Flow from Ops. 0000-0.1-0.10.100.10-
Debt/CF from Ops. 0000-5.2-88.968.51159.8-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA-24.2%-62.2%
Adj EPS NANA-14.9%-66.7%
BVPS-12.8%62.5%37.8%25.9%
Share Price 22.7% 50.8% 82.2% 507.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
-6.9-10.8-12.2-14.4-42.4-171.9192.4-138.8167.325.77.5
Op. Profit
Mgn %
00000-4.15-5.55.412.414.8
Net Profit
Mgn %
00000-4.15-5.18.16.94.8
Debt to
Equity
000027.4436.18.546.153-
Working Cap
Days
00000614187185130244414
Cash Conv.
Cycle
00000483-128370

Recent Performance Summary

Debt to equity has declined versus last 3 years average to 2.96

Return on Equity has declined versus last 3 years average to 7.50%

Sales growth has been subdued in last 3 years -24.16%

Net Profit has been subdued in last 3 years -14.94%

Sales growth is not so good in last 4 quarters at -55.82%

Latest Financials - Constronics Infra Ltd.

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 0.5 -
BVPS (₹.) 0.5 -
Reserves (₹ Cr.) -7 -
P/BV 86.15 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 5.12 / 39.51
All Time Low / High (₹) 0.50 / 60.00
Market Cap (₹ Cr.) 28.5
Equity (₹ Cr.) 7.2
Face Value (₹) 10
Industry PE 78.7

Management X-Ray of Constronics Infra:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Constronics Infra

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales000000.551.881.532.170.82
Operating Expenses 0.060.080.090.090.300.571.791.612.060.72
Manufacturing Costs000000.0100.010.010
Material Costs00000.190.431.621.281.630.30
Employee Cost 0.020.020.030.030.030.030.050.120.150.13
Other Costs 0.030.060.060.060.080.100.120.200.260.28
Operating Profit -0.06-0.08-0.09-0.09-0.30-0.020.09-0.080.120.10
Operating Profit Margin (%) ------4.1%5.0%-5.5%5.4%12.4%
Other Income 00000.17000.010.010.03
Interest 000000000.010.01
Depreciation 000000000.020.02
Exceptional Items 0000000000
Profit Before Tax -0.06-0.09-0.09-0.09-0.13-0.020.09-0.080.100.09
Tax 00000000-0.080.04
Profit After Tax -0.06-0.09-0.09-0.09-0.13-0.020.09-0.080.170.06
PAT Margin (%) ------4.1%4.9%-5.1%8.0%6.9%
Adjusted EPS (₹)-0.1-0.1-0.1-0.1-0.20.00.1-0.10.20.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 0.850.760.670.580.0200.100.020.190.25
Share Capital 7.217.217.217.217.217.217.217.217.217.21
Reserves -6.36-6.45-6.54-6.63-7.18-7.21-7.11-7.19-7.02-6.96
Minority Interest0000000000
Debt00000.670.800.800.790.950.74
Long Term Debt00000.67000.790.950.66
Short Term Debt000000.800.80000.07
Trade Payables0.020.010.040.040.010.320.010.010.030.01
Others Liabilities 0.600.680.740.830.010.030.020.04-0.030
Total Liabilities 1.461.451.451.450.711.160.940.861.150.99

Fixed Assets

Gross Block000000000.210.22
Accumulated Depreciation000000000.020.04
Net Fixed Assets000000000.200.18
CWIP 0000000000
Investments 0000000000
Inventories0.190.190.190.19000000
Trade Receivables000000.410.0500.040.15
Cash Equivalents 000000.040.120.120.150.52
Others Assets1.271.261.261.260.710.720.750.740.760.14
Total Assets 1.461.451.451.450.711.160.940.861.150.99

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity -0.02000-0.13-0.100.090.010.090.01
PBT -0.06-0.09-0.09-0.09-0.13-0.020.09-0.080.100.09
Adjustment 000000000.020.03
Changes in Working Capital 0.040.080.090.090-0.08-00.09-0.03-0.1
Tax Paid 000000000-0.01
Cash Flow From Investing Activity 00000000-0.210.65
Capex 00000000-0.21-0.01
Net Investments 0000000000
Others 0000000000.66
Cash Flow From Financing Activity 00000.130.140-0.020.15-0.30
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 00000000-0.01-0.01
Dividend Paid 0000000000
Others 00000.130.140-0.020.16-0.29
Net Cash Flow -0.0200000.040.09-0.010.030.37
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)-6.88-10.77-12.17-14.42-42.43-171.88192.41-138.79167.2725.7
ROCE (%)-6.78-10.74-12.13-14.1-20.15-2.9711.11-9.1411.229.94
Asset Turnover Ratio000000.581.81.72.160.77
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/A1N/A0.530.17
Working Capital Days
Receivable Days00000272440743
Inventory Days0000001000
Payable Days000046143384525

Constronics Infra Ltd Stock News

Constronics Infra Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Constronics Infra on 18-Mar-2024 16:59 is ₹39.50.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 18-Mar-2024 16:59 the market cap of Constronics Infra stood at ₹28.48.
The latest P/E ratio of Constronics Infra as of 18-Mar-2024 16:59 is 0.00.
The latest P/B ratio of Constronics Infra as of 18-Mar-2024 16:59 is 86.15.
The 52-week high of Constronics Infra is ₹39.51 and the 52-week low is ₹5.12.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Constronics Infra is ₹0.45 ( Cr.) .

About Constronics Infra Ltd

Invicta Meditek Limited (Invicta) incorporated in 1992 is a Public Limited company engaged in the manufacture of quality Orthopaedic Implants and Instruments.

Invicta Meditek manufacture the quality Orthopaedic Implants and Instruments. Invicta serves the field of Orthopaedics by supplying products for Total Joint Replacement systems, Trauma Implants and Associated Instruments. The product range also includes implants for Hemi-Arthroplasty, all types of Dynamic Compression and round hole plates, Screws with Cortical, Cancellous profiles, special thread sizes and in all diameters (with and without cannulation) and DHS/ DCS systems. The Joint Replacement Systems for Knee, Hip, Shoulder and Ankle are manufactured under license from Endotec Inc., USA.

Invicta has established a full-fledged machine shop with sophisticated, state of the art machinery required to meet the challenging, stringent quality requirements of the Orthopaedic implants and the high levels of accuracy required for the instruments used in joint replacement and other critical surgical operations.

Invicta lays special emphasis on achieving customer satisfaction by demonstrating the ability to consistently provide products that meet and exceed customer requirements. The Quality Control Department is equipped with the latest tools and instruments maintaining the strict quality standards demanded by the orthopaedic community.

Invicta’s product portfolio includes:-Total Joint Replacements for Knee, Hip, Ankle, Shoulder (under license from Endotec Inc., USA) -trauma implants (plates, screws, nails etc) -associated instrumentation

Product range of the company includes:

  • BP Hiflex Knee
  • Hip Implants
  • Trauma Implants
  • Conventional Implants
  • Instruments

Achievements/ recognition :

  • It is an ISO 13485-2003 & CE certified company.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.